Supporting Sexual Recovery in Women With Bladder Cancer

NCT07091565 | Enrolling By Invitation DMC

• 1 other identifier: 335939
• Study Type: observational
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

This study looks at how bladder cancer and removing the bladder can affect women's sexual well-being. Bladder cancer can be more serious in women, and treatment like bladder removal can impact how they feel about themselves and their relationships. Women who've gone through this say it's important to talk about and get support for their sexual recovery. The study has three main parts. First, it reviews what is already known. Next, it involves talking to women with bladder cancer and the doctors and nurses who care for them. Finally, the team will use what they learn to create a toolkit to help healthcare workers support women's sexual recovery. Women with bladder cancer are helping to design this study. Their input shapes the questions and tools. The final toolkit will include training for doctors and nurses and be shared online and through charities. The aim is to make this part of regular healthcare.

Conditions

Bladder Cancer; Cystectomy; Female Sexual Dysfunction

Keywords

Bladder cancer; transitional cell carcinoma; radical cystectomy; anterior exenteration; exenteration; sexual function; women; female; gynaecological organs

Outcome Measures

Primary Outcomes (1)

• Qualitative only

  Thematic analysis following an inductive framework approach to elicit codes and themes from the interviews.

  01/08/25-01/06/26

Secondary Outcomes (1)

• Intervention development

  06/2026-06/2027

Study Arms (2)

Patient

Experienced patients

Other: Qualitative interview/Focus group

HCP

Experienced healthcare professionals

Other: Qualitative interview/Focus group

Interventions

Qualitative interview/Focus group OTHER

Participants will take part in a 1:1 interview or focus group

HCP; Patient

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Female bladder cancer patients who have undergone bladder removal.

You may not qualify if:

• Those without professional registration

Sponsors & Collaborators

• King's College London: lead
• Guy's & St Thomas' NHS FT: collaborator
• The Royal Marsden NHS FT: collaborator
• Sheffield Teaching Hospitals NHS FT: collaborator

Study Sites (1)

King's College, London

London, United Kingdom

Location

MeSH Terms

Conditions

Urinary Bladder Neoplasms; Carcinoma, Transitional Cell

Interventions

Focus Groups

Condition Hierarchy (Ancestors)

Urologic Neoplasms; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Urinary Bladder Diseases; Urologic Diseases; Male Urogenital Diseases; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 21, 2025
• First Posted: July 29, 2025
• Study Start: August 1, 2025
• Primary Completion (Estimated): June 1, 2026
• Study Completion (Estimated): June 1, 2029
• Last Updated: August 3, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

GB (1)